Evidence map›Paper›PMID 36052067›Full record

ArticleFrontiers in immunology2022

Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation.

Archana Gopalakrishnan, John Joseph, Kari Ann Shirey, Achsah D Keegan, Marina S Boukhvalova, Stefanie N Vogel, Jorge C G Blanco

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Meeting the Challenge of Controlling Viral Immunopathology.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Archana GopalakrishnanDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, United States.
John JosephSigmovir Biosystems, Inc., Rockville, MD, United States.
Kari Ann ShireyDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, United States.
Achsah D KeeganDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, United States.
Marina S BoukhvalovaSigmovir Biosystems, Inc., Rockville, MD, United States.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, United States.
Jorge C G BlancoSigmovir Biosystems, Inc., Rockville, MD, United States.
University of Maryland, Baltimore · USSigmovir Biosystems (United States) · US

Funding

IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infectionR01AI143845 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KEEGAN, ACHSAH D., VISCARDI, ROSE MARIE · 2019 to 2023
$3.1M
Macrophage differentiation and disease outcome in influenza infectionR01AI123371 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
Insulin Receptor Substrate Signaling in Pulmonary HypertensionR01HL135022 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI KEEGAN, ACHSAH D. · 2018 to 2022
$2.0M
RSV-induced M2 macrophage differentiation: role of TLR4/PPARg/RXR signaling axis (80)R21AI163543 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2021 to 2022
$432k
Neuroendocrine control of TLR4-dependent inflammation in influenzaR21AI159507 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SHIREY, KARI ANN · 2021 to 2022
$411k
RXR/PPARg heterodimer agonists for treating virus-induced acute lung injuryR03AI186104 · NIAID · SIGMOVIR BIOSYSTEMS, INC. · PI BLANCO, JORGE C · 2024 to 2025
$148k
NHLBI NIH HHS R01 HL135022NIAID NIH HHS R01 AI123371NIAID NIH HHS R01 AI143845NIAID NIH HHS R03 AI186104NIAID NIH HHS R21 AI159507NIAID NIH HHS R21 AI163543
6 · The paper itself

Abstract

Many respiratory viruses cause lung damage that may evolve into acute lung injury (ALI), a cytokine storm, acute respiratory distress syndrome, and ultimately, death. Peroxisome proliferator activated receptor gamma (PPARγ), a member of the nuclear hormone receptor (NHR) family of transcription factors, regulates transcription by forming heterodimers with another NHR family member, Retinoid X Receptor (RXR). Each component of the heterodimer binds specific ligands that modify transcriptional capacity of the entire heterodimer by recruiting different co-activators/co-repressors. However, the role of PPARγ/RXR ligands in the context of influenza infection is not well understood. PPARγ is associated with macrophage differentiation to an anti-inflammatory M2 state. We show that mice lacking the IL-4Rα receptor, required for M2a macrophage differentiation, are more susceptible to mouse-adapted influenza (A/PR/8/34; "PR8")-induced lethality. Mice lacking

Indexed as

Acute Lung InjuryInfluenza, HumanAnimalsCyclooxygenase 2HumansInterleukin-4LigandsMacrophagesMicePPAR gammaRetinoid X ReceptorsCyclooxygenase 2Interleukin-4LigandsPPAR gammaRetinoid X ReceptorsAcute Lung InjuryinfluenzaM1 macrophageM2 macrophagePPARG

Identifiers

PMID36052067
PMCPMC9424652
OpenAlexW4291939943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.